See how FoundationOne® can open up more options for your patients

The FoundationOne® approach to opening more possibilities


Validated, comprehensive assays that detect alterations across the entire coding sequence of hundreds of genes that may be altered in solid tumours or hematologic cancers


Backed by deep expertise to help you better leverage results, with detailed reports that frame them in the context of current scientific evidence and clinical data, and tools that help connect you with physicians with similar patients


Able to identify all classes of genomic alterations with >99% positive predictive value — up to 3X more relevant genomic alterations than standard HotSpot panels